Mesalamine-induced hypersensitivity pneumonitis

Harefuah

Volumn 137, Issue 1-2, 1999, Pages

  Zamir, D ^a   Weizman, J ^a   Zamir, C ^a   Fireman, Z ^a   Weiner, P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; MESALAZINE;

ADULT; ALLERGIC PNEUMONITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; EOSINOPHILIA; FEMALE; HUMAN; LUNG INFILTRATE; ORAL DRUG ADMINISTRATION; PROCTITIS; RADIODIAGNOSIS; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLITIS, ULCERATIVE; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MESALAMINE; PNEUMONIA; PROCTITIS;

EID: 0032884037     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sleisenger MH & Fordtran SZ, Gastrointestinal Disease, 5th ed. WB Saunders Co, Philadelphia, 1993, pp 1287-1288.
2. Ireland A & Jewell DP, Sulfasalazine and the new salycilates. Eur J Gastroenterol Hepatol, 1989; 1: 43.
3. Swinburn CR, Jackson GJ, Cobdon I & al, bronchiolitis obliterans organizing pneumonia in a patient with ulcerative colitis. Thorax 1988; 43: 735-736.
4. Reinoso MA, Schroeder KW & Pisani RJ, Lung disease associated with orally administered mesalamine for ulcerative colitis. Chest, 1992; 101: 1469-1471.
5. Muzzi A, Ciani G, Bianchini D & al, Adverse pulmonary effects of mesalamine (letter). Chest, 1995; 108: 1181.
6. Welte T, Hamma H & Fable H, Mesalazine alveolitis. Lancet, 1991; 338: 1273.
7. Le Gros V, Saveuse H & Lesur G, Lung and skin hypersensitivity to 5-aminosalycylic acid. Br Med J, 1991; 1: 970.
8. Hesselmann J, Kunn M, Ostendorf PC & al, Acute alveolitis in ulcerative colitis: extra-intestinal organ complication or drug side effect, (ulcerosa: extraintestinale organkomplikation oder medikamenten nebenwurkung). Leber Magen Darm, 1991; 21: 26-28.
9. Lagler U, Schulthess KH & Kuhn M, Akute alveolitis under mesalazin. Schweiz Med Wochenschr, 1992; 122: 1332-1334.
10. Honeybourne D, Mesalazine toxicity. Br Med J, 1994; 308: 533-534.
11. Bitton A, Peppercorn MA, Hanrahan JP & al, Mesalamine induced lung toxicity. Am J Gastroenterol, 1996; 91: 1039-1040.
12. Kraft SC, Earle RH, Roesler M & al, Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Int Med, 1976; 136: 454-459.
13. Karasalihoglu A, Kutlu K & Yilmaz T, Obstrauction laryngotracheale en cas de colite ulcereuse. Rev Uryngol, 1988; 109: 469-471.
14. Desai SJ, Gephardt GN, Holdsworth CD & al, Diffuse panbronchiolitis preceding ulcerative colitis. Chest, 1989; 45: 1342-1344.
15. Swinburn CR, Jackson GJ, Cobden J & al, Bronchiolitis obliterans organizing pneumonia in a patient with ulcerative colitis. Chest, 1992; 101: 585-586.
16. Isenberg JI, Goldslein H, Koren AR & al, Pulmonary vasculitis - an uncommon complication of ulcerative colitis. N Engl J Med, 1968; 179: 1376-1377.
17. Becker SA, Wishnitzer R, Borwin S & al, Myopericarditis-associated with inflammatory bowel disease. J Clin Gastroenterol, 1981; 3: 267-270.
18. Camus P, Piard F, Ashcroft T & al, The lung in inflammatory bowel disease. Medicine, 1993; 72:151-183.
19. Harrison's Principles of Internal Medicine, vol. 2, 12th ed. McOraw Hill, International Edition 1994, pp 1173-1176.
20. Akoun GM, Millerton BJ, Mayaud CM & al, Natural history of drug induced pneumonitis. Elsevier, Amsterdam, 1989, pp 3-9.
21. Cooper AJ, White DA & Matthay RA, Drug induced pulmonary disease-Part 2: noncytotoxic drugs. Am Rev Respir Dis, 1983; 133: 448-450.
22. Jones GB & Malone PNS, Sulphasalazine induced lung disease. Thorax, 1972; 27: 713.
23. Thomas P, Seaton A, Edwards J & al, Respiratory disease due to sulphasalazine. Eur J Respir Dis, 1983; 64: 229-233.
24. Sigvaldason A & Sorenson S, Interstitial pneumonia due to sulphasalazine. Clin Allergy, 1974; 4: 41-47.
25. Davies D & MacFarlane A, Fibrosing alveolitis and treatment with sulphasalazine. Gut, 1974; 15: 185-188.
26. Agnholt J, Sorenson HT, Rasmussen N & al, Cardiac hypersensitivity to 5-aminosalicylic acid. Lancet, 1985; 1: 1135.
27. Desmeules J, Vogt N, Loizeau SK & al, Pericadite recidivante induite par lamesalazine (5-ASA). Therapie, 1994; 49: 355-363.
28. Jenss H, Becker EW & Weber P, Pericaridal effusion during treatment with 5-aminosalicylic acid in a patient with Crohn's disease. Am J Gastroenterol, 1990; 85: 332-333.
29. Kristensen KS. Hoegholm A, Bohr L & al, Fatal myocarditis associated with mesalamine. Lancet, 1990; I: 605.
30. Dent MT, Ganapathy S, Holdswortlt CD & al, Mesalazine induced lupus-like syndrome. Br Med J, 1992; 2: 159.
31. Von Muhlendahl KE, Nephritis durch 5-aminosalicylsaure. Ditsch Med Wochenschr, 1989; 114: 236.
32. Woodward DK, Peripheral neuropathy and mesalazine. Br Med J, 1989; 11: 1224.